Breast Imaging: Page 57

Xcision secures Italian GammaPod contract
By AuntMinnieEurope.com staff writers
Medical technology company Xcision Medical Systems has signed a contract for its GammaPod stereotactic radiotherapy breast cancer system with an Italian hospital.
April 16, 2018
Large U.K. study gets specific on breast ultrasound
By Rebekah Moan
Extended ipsilateral breast ultrasound can detect a significant number of extra cancers compared with the standard screening protocol alone, U.K. researchers of an extensive study have revealed. Less effect was demonstrated for complete contralateral breast ultrasound, they added.
April 16, 2018
2016 11 01 16 42 02 992 Ultrasound Exam Transducer 400
Multiparametric MRI shines for suspected breast cancer
By Wayne Forrest
Dynamic contrast-enhanced MRI and diffusion-weighted imaging each have advantages and disadvantages for assessing suspicious breast lesions. The optimal approach is multiparametric MRI using both methods, according to a new study published online in Investigative Radiology.
April 15, 2018
2018 04 11 19 15 0063 Mp Mri Dce Dwi Mri Insider 20180411193510
Hyperechogenic breast lesions: Not so benign
By Rebekah Moan
Hyperechogenic breast lesions are rare and described as generally benign. That being the case, these lesions are often overlooked and a biopsy is not recommended. But is that wise? New research suggests it is not the ideal approach.
April 12, 2018
2018 04 12 23 48 1384 Risk Magnifying Glass2 400
Breast cancer therapies: Risk to the heart?
By AuntMinnieEurope.com staff writers
The risk of death from heart disease in breast cancer patients following radiotherapy or chemotherapy is no higher than it is among the average population, according to a large study by German scientists. Good risk management in hospitals and control screenings at short intervals seem to make up for elevated risks, they added.
April 9, 2018
DBT only slightly more expensive than digital mammo
By Rebekah Moan
Is breast cancer screening with synthesized 2D digital mammography and digital breast tomosynthesis (DBT) much more expensive than conventional mammography? No, according to Italian researchers who presented their findings at ECR 2018. DBT costs only 20% more, and it detects 40% more cancers.
March 29, 2018
2018 03 29 18 48 8384 Euros 400
BIR issues free podcast on breast MRI
By AuntMinnieEurope.com staff writers
The British Institute of Radiology (BIR) has posted a podcast on multiparametric breast MRI featuring Dr. Katja Pinker, a professor of radiology at Memorial Sloan Kettering Cancer Center in New York City and senior editor of BJR|case reports.
March 26, 2018
Growth in breast tumor size may reflect screening drop
By Rebekah Moan
The average size of breast tumors has increased significantly since 2001, and this may reflect declining screening rates, researchers reported at the European Breast Cancer Conference in Barcelona, Spain. The finding is in stark contrast to the 1980s and 1990s, when the average size of tumors decreased dramatically.
March 22, 2018
2017 01 16 14 55 29 676 Barcelona Sagrada Familia 400
Swiss claim drop in breast cancer not due to mammography
By Rebekah Moan
Breast cancer mortality dropped strongly from the 1990s onward in Switzerland, but is the decline due to mammography screening programs? The authors of a new study published on 14 March in BMJ Open say that's possible, but it could also be due to other factors such as advances in treatment.
March 20, 2018
2018 01 15 20 27 2375 Swiss Flag 400
EBCC: Polygenic risk scores predict 2nd breast cancer
By AuntMinnieEurope.com staff writers
Polygenic risk scores can predict the risk of a second breast cancer in BRCA breast cancer survivors, according to research presented at the European Breast Cancer Conference (EBCC) in Barcelona, Spain.
March 20, 2018
PET/MRI, PET/CT can add to initial breast cancer staging
By Wayne Forrest
Both PET/MRI and PET/CT perform admirably in the initial staging of breast cancer patients, but there are subtle nuances between the hybrid modalities of which clinicians should be aware, according to a Swiss study presented earlier this month at ECR 2018 in Vienna.
March 19, 2018
2018 03 21 15 53 4925 2018 03 20 Mol Thumb
Volpara participates in U.K. breast screening research
By AuntMinnieEurope.com staff writers
Breast imaging software developer Volpara Solutions said its VolparaDensity software will be used in the second stage of the U.K.'s Predicting Risk of Cancer at Screening (PROCAS) study, a research project that seeks to improve prediction of breast cancer risk in women receiving routine breast screening.
March 15, 2018
Previous Page
Page 57 of 139
Next Page